(Q37153633)

18 August 2017

1 reference

title

RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection (English)

1 reference

18 August 2017

1 reference

6

Thomas Unger

1 reference

18 August 2017

7

Salim Yusuf

1 reference

18 August 2017

4

Roland Schmieder

1 reference

18 August 2017

Christian Werner

1

1 reference

18 August 2017

Magnus Baumhäkel

2

1 reference

18 August 2017

Koon K Teo

3

1 reference

18 August 2017

Johannes Mann

5

1 reference

18 August 2017

Michael Böhm

8

1 reference

18 August 2017

publication date

3 May 2008

1 reference

Clinical Research in Cardiology

18 August 2017

published in

1 reference

18 August 2017

volume

97

1 reference

18 August 2017

issue

7

1 reference

18 August 2017

page(s)

418-431

1 reference

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00392-008-0668-3

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-008-0668-3

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-008-0668-3

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-008-0668-3

A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein

21 January 2018

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article

1 reference

12 December 2020

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Rationale for double renin-angiotensin-aldosterone system blockade

1 reference

12 December 2020

Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?

1 reference

12 December 2020

Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy

1 reference

12 December 2020

Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction

1 reference

12 December 2020

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

1 reference

12 December 2020

Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy

1 reference

12 December 2020

Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia

1 reference

12 December 2020

Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Use of ramipril in preventing stroke: double blind randomised trial

1 reference

12 December 2020

Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity

1 reference

12 December 2020

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial

1 reference

12 December 2020

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

1 reference

12 December 2020

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

12 December 2020

Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study

1 reference

12 December 2020

The telmisartan Programme of Research tO show Telmisartan End-organ proteCTION (PROTECTION) Programme

1 reference

12 December 2020

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

12 December 2020

Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes In vitro

1 reference

12 December 2020

Preventing microalbuminuria in type 2 diabetes

1 reference

12 December 2020

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation

1 reference

12 December 2020

Oxidative stress on progenitor and stem cells in cardiovascular diseases

1 reference

12 December 2020

Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro

1 reference

12 December 2020

Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients

1 reference

12 December 2020

Preventing renal complications in diabetic patients: the Diabetics Exposed to Telmisartan And enalaprIL (DETAIL) study

1 reference

12 December 2020

Programmed myocyte cell death affects the viable myocardium after infarction in rats

1 reference

12 December 2020

The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients

1 reference

12 December 2020

Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall

1 reference

12 December 2020

Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome

1 reference

12 December 2020

Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?

1 reference

12 December 2020

Angiotensin in the kidney: a key to understanding hypertension?

1 reference

12 December 2020

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1 reference

12 December 2020

Endothelial function in health and disease: new insights into the genesis of cardiovascular disease

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria

1 reference

12 December 2020

The difficult conception, birth and delivery of a renin inhibitor: controversies around aliskiren

1 reference

12 December 2020

Pathophysiological regulation of the AT1-receptor and implications for vascular disease

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

12 December 2020

Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT.

1 reference

12 December 2020

Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?

1 reference

12 December 2020

Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients

1 reference

12 December 2020

The AT2 receptor--a matter of love and hate

1 reference

12 December 2020

Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists

1 reference

12 December 2020

Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement

1 reference

12 December 2020

ACE inhibition in secondary prevention: are the results controversial?

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Renin-angiotensin system and cardiovascular risk

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

12 December 2020

Systematic review of combined angiotensin-converting enzyme inhibition and angiotensin receptor blockade in hypertension

1 reference

12 December 2020

Low-grade albuminuria and cardiovascular risk : what is the evidence?

1 reference

12 December 2020

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

1 reference

12 December 2020

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

1 reference

12 December 2020

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

12 December 2020

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice

1 reference

12 December 2020

The ONTARGET/TRANSCEND Trial Programme: baseline data

1 reference

12 December 2020

Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

Long-term potential of angiotensin receptor blockade for cardiovascular protection in hypertension: the VALUE trial. Valsartan Antihypertensive Long-term Use Evaluation

1 reference

12 December 2020

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

1 reference

12 December 2020

Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness

1 reference

12 December 2020

Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation

1 reference

12 December 2020

Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.

1 reference

12 December 2020

Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets

1 reference

12 December 2020

Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs

1 reference

12 December 2020

10.1007/S00392-008-0668-3

Identifiers

DOI

1 reference

18 August 2017

1 reference